Navigation Links
Lexicon to Present at Two Major Healthcare Investor Conferences
Date:6/3/2010

lopment of its potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2009, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Lexicon Announces Pricing of Common Stock in Public Offering
2. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Fourth Quarter and Full Year Financial Results
3. Lexicon Announces Proposed Offering of 27,500,000 Shares of Common Stock
4. Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
5. Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28, 2009
6. Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome
7. Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer
8. Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
9. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2009 Financial Results on April 28, 2009
10. Lexicon Pharmaceuticals 2008 Annual Report to Stockholders Available Online
11. Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , Aug. 3, 2015  Merck KGaA, Darmstadt, ... and top-quality high-tech products in the healthcare, life science ... US-based company Nano-C, their development and launch of promising ... photovoltaics (OPV). Merck KGaA, Darmstadt, Germany ... growing OPV sector. Novel derivatives: highly stable, ...
(Date:8/3/2015)... , August 3, 2015 According ... on 3D Cell Culture: Asia ... Market Research, the global 3D cell culture market was valued at ... expand at a CAGR of 29.1% to account for ... Report with TOC:  http://www.persistencemarketresearch.com/market-research/3d-cell-cultures-market.asp 3D cell ...
(Date:7/31/2015)... -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or ... of cord blood collection, laboratory testing, hematopoietic stem cell ... the Company has filed its Annual Report on Form ... filed Form 20-F includes audited financial statements for the ... can be accessed by visiting the U.S. Securities and ...
(Date:7/30/2015)... ... July 30, 2015 , ... Tronics, a designer ... & Marketing Director. , With more than 25 years of experience in ... Tronics’ business development activities worldwide. He brings to the company his strong expertise ...
Breaking Biology Technology:Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 4Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 2Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 3Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 4China Cord Blood Corporation Files Its Annual Report on Form 20-F 2Tronics appoints Francois Vieillard as Sales and Marketing Director 2
... exciting at the beginning. , ,Two companies enter into ... Web site, or have a service provider deliver a range ... work out perfectly well and the parties come to the ... has been performed or received. , ,However, sometimes the ...
...
... Fiserv Inc. has released a software suite ... , ,CRM software keeps track of the interactions between ... times, allowing the business to coordinate its customer service. ... with other systems from Fiserv, which makes a wide ...
Cached Biology Technology:Arbitration can help when IT deals go sour 2Arbitration can help when IT deals go sour 3
(Date:7/31/2015)... 2015 A 10 a. Conferência Internacional ... BGI de 22-25 de outubro de 2015, em ... está celebrando seu 10 o. aniversário este ano. Desde ... das reuniões mais influentes do mundo no ramo das ... e prazerosos. A ICG-10 se concentra ...
(Date:7/31/2015)... 2015 La 10 th International Conference on ... BGI del 22 al 25 de octubre de 2015 en ... la conferencia celebra su décimo aniversario. Desde su inauguración en ... las reuniones anuales más influyentes del mundo en el campo ... entusiastas y mejores a nivel científico. ICG-10 ...
(Date:7/31/2015)... OXFORD, Conn. , Jul. 31, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... announces that it has filed provisional patent 62/198989 for ... This invention highlights a method to advance crypto-currencies ... technology by introducing a common, uniform way to manage ...
Breaking Biology News(10 mins):A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4
... at Polytechnic Institute of New York University (NYU-Poly) have ... single virus particles in solution, an advance that may ... shrink test result wait times from weeks to minutes. ... and member of the Othmer-Jacobs Department of Chemical and ...
... is largely restricted to the eastern edge of the New England Tableland, ... raised this flowering plant, until now classified as a variety of the ... of a distinct species. The study was published in the open access ... the family of flowering plants that includes the Banksia and ...
... After waking up, the concentration of the stress hormone ... only for grown-ups but for babies as well. A ... has reported this finding in the journal Psychoneuroendocrinology ... possibility to already research the activity of the stress ...
Cached Biology News:By detecting smallest virus, researchers open possibilities for early disease detection 2By detecting smallest virus, researchers open possibilities for early disease detection 3Botany student proves 'New England Banksia' a distinct species 2New method: Research team analyzes stress biology in babies 2
... x2 Dual-Binary Analytical System more than doubles ... and LC/MS. The fast analysis cycles of ... up to 100% in tandem mode. Difficult ... mode. Using backflush or heartcut configurations, on-line ...
... The PerkinElmer kit provides reagents for immune ... serum and plasma samples using a combination ... are then neutralized and transferred to microplate ... specific mouse monoclonal antibody to HIV-1 p24. ...
Request Info...
... Tecans new Enzyme-Linked Immunosorbent Assay (ELISA) analyzer ... is a dedicated EVO platform for reliableELISA ... and incubation units operated by the new ... available in three sizes - 100, 150, ...
Biology Products: